BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 34118772)

  • 41. Prognostic significance of the neural invasion in oral squamous cell carcinoma.
    da Dolens ES; de Morais EF; Paranaíba LMR; Rangel ALCA; Almangush A; Salo T; Brennan PA; Coletta RD
    J Oral Pathol Med; 2023 Jul; 52(6):476-482. PubMed ID: 36850021
    [TBL] [Abstract][Full Text] [Related]  

  • 42. An Ultra-Deep Targeted Sequencing Gene Panel Improves the Prognostic Stratification of Patients With Advanced Oral Cavity Squamous Cell Carcinoma.
    Liao CT; Chen SJ; Lee LY; Hsueh C; Yang LY; Lin CY; Fan KH; Wang HM; Ng SH; Lin CH; Tsao CK; Chen IH; Chang KP; Huang SF; Kang CJ; Chen HC; Yen TC
    Medicine (Baltimore); 2016 Feb; 95(8):e2751. PubMed ID: 26937903
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Targeted sequencing reveals TP53 as a potential diagnostic biomarker in the post-treatment surveillance of head and neck cancer.
    van Ginkel JH; de Leng WW; de Bree R; van Es RJ; Willems SM
    Oncotarget; 2016 Sep; 7(38):61575-61586. PubMed ID: 27528217
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Identification of High-Risk Subgroups of Patients With Oral Cavity Cancer in Need of Postoperative Adjuvant Radiotherapy or Chemo-Radiotherapy.
    Chen WC; Lai CH; Fang CC; Yang YH; Chen PC; Lee CP; Chen MF
    Medicine (Baltimore); 2016 May; 95(22):e3770. PubMed ID: 27258508
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Prognostic significance of extranodal extension in oral cavity squamous cell carcinoma with occult neck metastases.
    Mamic M; Lucijanic M; Manojlovic L; Muller D; Suton P; Luksic I
    Int J Oral Maxillofac Surg; 2021 Mar; 50(3):309-315. PubMed ID: 32713777
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Staging more important than grading? Evaluation of malignancy grading, depth of invasion, and resection margins in oral squamous cell carcinoma.
    Wunschel M; Neumeier M; Utpatel K; Reichert TE; Ettl T; Spanier G
    Clin Oral Investig; 2021 Mar; 25(3):1169-1182. PubMed ID: 32601998
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Clinicopathological and immunohistochemical evaluation of oral and oropharyngeal squamous cell carcinoma in Chilean population.
    Rivera C; González-Arriagada WA; Loyola-Brambilla M; de Almeida OP; Coletta RD; Venegas B
    Int J Clin Exp Pathol; 2014; 7(9):5968-77. PubMed ID: 25337241
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Comprehensive Genome profile testing in head and neck cancer.
    Kuroki M; Iinuma R; Okuda H; Terazawa K; Shibata H; Mori KI; Ohashi T; Makiyama A; Futamura M; Miyazaki T; Horikawa Y; Ogawa T
    Auris Nasus Larynx; 2023 Dec; 50(6):952-959. PubMed ID: 37164815
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Postoperative radiotherapy in squamous cell carcinoma of the oral cavity: the importance of the overall treatment time.
    Langendijk JA; de Jong MA; Leemans CR; de Bree R; Smeele LE; Doornaert P; Slotman BJ
    Int J Radiat Oncol Biol Phys; 2003 Nov; 57(3):693-700. PubMed ID: 14529773
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Improvement in survival of patients with oral cavity squamous cell carcinoma: An international collaborative study.
    Amit M; Yen TC; Liao CT; Chaturvedi P; Agarwal JP; Kowalski LP; Ebrahimi A; Clark JR; Kreppel M; Zöller J; Fridman E; Bolzoni VA; Shah JP; Binenbaum Y; Patel SG; Gil Z;
    Cancer; 2013 Dec; 119(24):4242-8. PubMed ID: 24114787
    [TBL] [Abstract][Full Text] [Related]  

  • 51. c-Met expression is a marker of poor prognosis in patients with locally advanced head and neck squamous cell carcinoma treated with chemoradiation.
    Baschnagel AM; Williams L; Hanna A; Chen PY; Krauss DJ; Pruetz BL; Akervall J; Wilson GD
    Int J Radiat Oncol Biol Phys; 2014 Mar; 88(3):701-7. PubMed ID: 24521684
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A novel tumor mutational burden estimation model as a predictive and prognostic biomarker in NSCLC patients.
    Tian Y; Xu J; Chu Q; Duan J; Zhang J; Bai H; Yang Z; Fang W; Cai L; Wan R; Fei K; He J; Gao S; Zhang L; Wang Z; Wang J
    BMC Med; 2020 Aug; 18(1):232. PubMed ID: 32843031
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Validation of metabolic tumor volume as a prognostic factor for oral cavity squamous cell carcinoma treated with primary surgery.
    Zhang H; Seikaly H; Nguyen NT; Abele JT; Dziegielewski PT; Harris JR; O'Connell DA
    Oral Oncol; 2016 Jun; 57():6-14. PubMed ID: 27208838
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The Prognostic Value of Preoperative Albumin-to-Alkaline Phosphatase Ratio on Survival Outcome for Patients With Locally Advanced Oral Squamous Cell Carcinoma.
    Tsai MH; Chuang HC; Lin YT; Yang KL; Lu H; Huang TL; Tsai WL; Su YY; Fang FM
    Technol Cancer Res Treat; 2022; 21():15330338221141254. PubMed ID: 36426570
    [No Abstract]   [Full Text] [Related]  

  • 55. Mutation allele frequency threshold does not affect prognostic analysis using next-generation sequencing in oral squamous cell carcinoma.
    Ma J; Fu Y; Tu YY; Liu Y; Tan YR; Ju WT; Pickering CR; Myers JN; Zhang ZY; Zhong LP
    BMC Cancer; 2018 Jul; 18(1):758. PubMed ID: 30041611
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Depth of invasion alone as a prognostic factor in low-risk early-stage oral cavity carcinoma.
    Kozak MM; Shah J; Chen M; Schaberg K; von Eyben R; Chen JJ; Bui T; Kong C; Kaplan M; Divi V; Hara W
    Laryngoscope; 2019 Sep; 129(9):2082-2086. PubMed ID: 30604435
    [TBL] [Abstract][Full Text] [Related]  

  • 57. RCOR1 directly binds to MED28 and weakens its inducing effect on cancer stem cell-like activity of oral cavity squamous cell carcinoma cells.
    Xiang Z; Zhou S; Liang S; Zhang G; Tan Y
    J Oral Pathol Med; 2020 Sep; 49(8):741-750. PubMed ID: 32306431
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Prognostic Genomic Markers of Pathological Stage in Oral Squamous Cell Carcinoma.
    Kuk SK; Lee JI; Kim K
    Head Neck Pathol; 2023 Jun; 17(2):409-421. PubMed ID: 36586077
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Frameshift events predict anti-PD-1/L1 response in head and neck cancer.
    Hanna GJ; Lizotte P; Cavanaugh M; Kuo FC; Shivdasani P; Frieden A; Chau NG; Schoenfeld JD; Lorch JH; Uppaluri R; MacConaill LE; Haddad RI
    JCI Insight; 2018 Feb; 3(4):. PubMed ID: 29467336
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Prognostic impact of the prognostic nutritional index in cases of resected oral squamous cell carcinoma: a retrospective study.
    Abe A; Hayashi H; Ishihama T; Furuta H
    BMC Oral Health; 2021 Jan; 21(1):40. PubMed ID: 33482792
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.